REQUEST INFO

TDF Drug and Truvada Lawsuit


We are filing lawsuits on behalf of people with HIV who took one or more of Gilead’s Tenofovir Disoproxil Fumarate (TDF) drugs—Truvada, Viread, Atripla, Complera, and Stribild—and then allegedly suffered kidney disease and/or bone density loss.
Have you been impacted? Use the contact form, or call us at 1-800-567-4878, to see how Diamond & Diamond Lawyers can help.

About the Class Action / Mass Tort

The risks associated with Tenofovir were well-understood by the Defendants at the time they began developing and testing TDF-based drugs. 

As a result of taking the TDF-based drugs, individuals suffered harm and injuries including, but not limited to, decreased kidney function, renal failure, end-stage renal disease, renal impairment, chronic kidney disease, tubular dysfunction, chronic liver disease, Fanconi syndrome, reduced bone density, bone breaks/fractures, bone malformation, and tooth loss. 

This claim is being brought on behalf of all individuals who, during the period 2004 to the present were prescribed and ingested TDF-based drugs in Canada and experienced any of the harm and injuries described above.


Get in Touch With Us Today

Details about the Class Action / Mass Tort

The proposed lawsuit alleges that the maker of these drugs knew that there was a safer alternative to TDF and knowingly delayed and withheld the development, marketing and sale of the alternative, to maximize their profit from sales of Viread, Truvada, Atripla, Complera and Stribild. 

Due to the Defendants’ actions, Canadians were exposed to the more toxic and dangerous medication for over a decade and suffered permanent, debilitating, and sometimes fatal, injuries and harm relating to kidney and bone damage.

Have you or your family member been impacted? Use the contact form, or call us at 1-800-567-4878, to see how Diamond & Diamond Lawyers can help.

Updates (Related to the Class Action / Mass Tort)

– December 2021: We write to provide you with a further update to our August update. As mentioned in our last update, we have issued our Statement of Claim. We are awaiting a response from defence counsel and will be moving towards booking our first court appearance.

– August 2021: We write to provide you with a further update to our June 9th update. As mentioned in our last update, we are currently drafting a Statement of Claim and anticipate that claim will be issued in the near future. Once the claim is issued we will be proceeding with the next steps, which include booking a first court appearance.

Get the help you deserve

1-800-567-HURT

Call NOW for a free consultation

Diamond & Diamond Ontario Head Office

255 Consumers Road, 5th Floor, Toronto, Ontario

>> Learn More

Diamond & Diamond Alberta Head Office

4246 97 Street NW, Unit 100, Edmonton, Alberta

>> Learn More

Diamond & Diamond British Columbia Head Office

1727 West Broadway, Suite 400, Vancouver, British Columbia

>> Learn More

Barrie

17 Poyntz Street

Brampton

341 Parkhurst Square, Suite 5

Calgary

2713 14 St SW

Calgary

8060 Silver Springs Blvd NW #106

Calgary

1331 Macleod Trail SE, Suite 420

Edmonton

4246 97 Street NW, Unit 100

Hamilton

105 Main Street East, Suite 1500

Kelowna

1631 Dickson Avenue Suite 1100

London

256 Pall Mall St, Suite 102

Oakville / Mississauga

2939 Portland Drive, Suite 200

Oshawa

50 Richmond Street E, Unit # 108 B

Ottawa

955 Greenvalley Crescent, Unit 315

Sudbury

31 Larch Street, Unit 300

Surrey

1104 – 13737 96 Ave, Surrey, BC V3V 0C6

Thunder Bay

278 Algoma Street South

Toronto

255 Consumers Road, 5th Floor

Vancouver

1727 West Broadway, Suite 400

Windsor

13158 Tecumseh Rd. E. Unit 3B